Beate Beer

Is the toxicity of adjuvant aromatase inhibitor therapy underestimated? Complementary information from patient-reported outcomes (PROs)

Anne Oberguggenberger, Hubalek Michael, Monika Sztankay et al. · Breast Cancer Research and Treatment · 2011 · 80 citations · Full text

Drug Safety, Patient-reported Outcomes, Medicine +8

Association of Polymorphisms in Pharmacogenetic Candidate Genes (OPRD1, GAL, ABCB1, OPRM1) with Opioid Dependence in European Population: A Case-Control Study

Beate Beer, Robert Erb, Marion Pavlic et al. · PLoS ONE · 2013 · 72 citations · Full text

Genetics, Genetic Epidemiology, Human Polymorphism +19

Development and validation of a liquid chromatography–tandem mass spectrometry method for the simultaneous quantification of tamoxifen, anastrozole, and letrozole in human plasma and its application to a clinical study

Beate Beer, Birthe Schubert, Anne Oberguggenberger et al. · Analytical and Bioanalytical Chemistry · 2010 · 50 citations

Therapeutic Drug Monitoring, Medicine, Bioanalysis +12

3D Versus 2D Cell Culture

Michael W. Hess, Kristian Pfaller, Hannes Ebner et al. · Methods in cell biology · 2010 · 43 citations

Tissue Engineering, Engineering, Medicine +7

Adherence evaluation of endocrine treatment in breast cancer: methodological aspects

Anne Oberguggenberger, Monika Sztankay, Beate Beer et al. · BMC Cancer · 2012 · 40 citations · Full text